The global pandemic has caused the health and life science industry to change more in the last three years than it has in the last three decades. The accelerated adoption of digital in all areas of the healthcare landscape has dramatically altered the patient journey. Now more than ever, healthcare stakeholders need support from pharma to help deliver optimal care to patients. But are current engagement strategies working as well as they could be?
Watch part two in a series, Evolving Patient Journeys, in which experts from across Inizio explore why, despite best intentions, patient engagement solutions can fall short of expectations.
Using a typical product profile scenario in an area of high unmet need, they demonstrate how pharmaceutical manufacturers can improve the patient journey through a combination of insight generation, engagement strategy and activation.
Research Partnership Director Liza Pliss is joined by Nareda Mills, Global President, Patient Solutions at Ashfield Engage and Edward Gajewski, Principal at Nuvera Life Science Consulting.
They share best-practice and practical insight on how to develop suitable research programs, strategies and initiatives that successfully support stakeholders throughout the journey, improve brand engagement and ultimately improve patient outcomes.
What you will learn:
- How to gather the right insights for early commercialization and to guide the design of clinical trials
- How to gain a foundational patient understanding in a new disease area or for a new asset in an area of unmet need
- How to get a deeper understanding of the changing emotional needs of patients and their new digital behaviours in areas of chronic illness
- How to deploy engagement tactics throughout the journey and product lifecycle